Cargando…
Reduced COVID-19 Vaccine Response in Patients Treated with Biologic Therapies for Asthma
Autores principales: | Runnstrom, Martin C., Morrison-Porter, Andrea, Ravindran, Mayuran, Quehl, Hannah, Ramonell, Richard P., Woodruff, Matthew, Patel, Rahulkumar, Kim, Caroline, Haddad, Natalie S., Lee, F. Eun-Hyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872804/ https://www.ncbi.nlm.nih.gov/pubmed/35180044 http://dx.doi.org/10.1164/rccm.202111-2496LE |
Ejemplares similares
-
Reduced SARS-CoV-2 Vaccine Response in Patients Treated with Biologic Therapies for Asthma and Atopic Dermatitis
por: Runnstrom, Martin, et al.
Publicado: (2022) -
PATIENTS WITH ASTHMA OR ATOPIC DERMATITIS TAKING BIOLOGIC THERAPIES HAVE REDUCED SARS-COV-2 VACCINE RESPONSE AT SIX MONTHS
por: RUNNSTROM, MARTIN C, et al.
Publicado: (2022) -
Reply to Liao et al.: SARS-CoV-2 mRNA Vaccine Antibody Response in Patients with Asthma Receiving Biologic Therapy: A Real-World Analysis
por: Runnstrom, Martin C., et al.
Publicado: (2022) -
Utilizing Predictive Inflammatory Markers for Guiding the Use of Biologicals in Severe Asthma
por: Runnstrom, Martin, et al.
Publicado: (2022) -
Poor immunogenicity upon SARS-CoV-2 mRNA vaccinations in autoimmune SLE patients is associated with pronounced EF-mediated responses and anti-BAFF/Belimumab treatment
por: Faliti, Caterina E., et al.
Publicado: (2023)